Sequencing Technologies
High-throughput short-read and long-read sequencing systems designed for speed, depth, and reproducibility across translational research programs.
DemyHealth Genomics Research Institute
Building the future of clinical genomics with scientific authority.
A premium biotech platform integrating sequencing technologies, robust NGS pipelines, advanced bioinformatics, and precision medicine frameworks for translational discovery and enterprise healthcare outcomes.
Institute capabilities
Integrated genomic science from sample to clinical insight
NGS Pipelines
End-to-end wet-lab and computational NGS workflows with quality controls, variant calling, annotation, and scalable reporting standards.
Oncology Genomics
Comprehensive tumor profiling, somatic mutation discovery, and biomarker interpretation supporting precision oncology and therapy stratification.
Infectious Disease Genomics
Pathogen genome surveillance, antimicrobial resistance analysis, and rapid genomic response pipelines for outbreak intelligence.
Bioinformatics
Expert algorithmic and statistical analysis transforming complex omics datasets into actionable biological and clinical evidence.
Precision Medicine
Genomic insights integrated with phenotypic and clinical context to guide individualized care pathways and treatment optimization.
Population-scale intelligence
Molecular epidemiology for real-world public health action
DemyHealth combines molecular epidemiology with advanced analytics to map transmission dynamics, monitor variant emergence, and inform strategic interventions for healthcare systems, payers, and public health institutions.
Research pillars
- • Longitudinal surveillance across oncology and infectious diseases
- • AI-guided variant prioritization and signal detection
- • Cross-disciplinary translational bioinformatics teams
- • Enterprise-grade governance, compliance, and reporting